Insulet appoints Jonathan J. Mazelsky as independent director effective July 1, 2026

INSULET CORP

Mazelsky is Executive Chair of IDEXX Laboratories and former CEO (2019-2026).
He will receive an initial RSU grant with fair value $216,548 and standard cash compensation.
Appointment expands Board; Mazelsky will stand for election at 2027 annual meeting.
No material arrangements or related-party transactions disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.